If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Trading Update

28 Nov 2019 07:00

RNS Number : 9036U
TClarke PLC
28 November 2019
 

TClarke plc

 

TRADING UPDATE

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, today issues a trading update for the period from 1 July 2019 to date.

 

Trading performance

 

At the half year, the Group reported a 25% increase in underlying operating profit and we are pleased to report that trading has continued strongly in the second half of the year. Accordingly, the Board expects the results for the full year ending 31 December 2019 to be in-line with market expectations.

 

We expect to report an underlying operating profit before interest and taxation of approximately ÂŁ10m (2018: ÂŁ8.8m) which is in-line with our stated strategy to achieve our key financial target of an underlying operating margin of 3%.

 

We have made good progress in replenishing our forward order book, which currently stands at ÂŁ361m. Reassuringly, revenues of ÂŁ232m for 2020 have already been secured, against an equivalent figure of ÂŁ230m at this time last year and up from ÂŁ182m at the interims. In addition, our teams across the UK are actively negotiating a number of major schemes which provide further visibility for both 2020 and 2021.

 

Outlook

 

Our long-standing, high quality reputation and the strength of the relationships with our blue-chip clients is a key asset for TClarke. Furthermore, our strong balance sheet continues to be a significant differentiator and enables us to win and deliver projects of a scale which positions us well for further growth. We continue to adhere to a strict bidding policy supporting our sustainable operating margin at 3% going forward.

Looking ahead, we approach the new financial year in a strong position, both operationally and financially which gives the Board confidence for the Group's prospects for 2020 and beyond.

-ends-

 

28 November 2019

 

For further information contact:

 

TClarke plc

Mark Lawrence - Group Chief Executive

Trevor Mitchell - Finance Director

David Lanchester - Company Secretary

Tel: 020 7997 7400

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Max Hartley (Corporate Finance)

Nick Searle (Sales)

Tel: 020 7397 8900

www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLBDBGSDBGCR
Date   Source Headline
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change
5th May 20217:00 amRNSAGM - Trading Update
29th Apr 20217:00 amRNSDirector / PDMR Shareholding
28th Apr 20217:00 amRNSDirector / PDMR Shareholding
12th Apr 202110:40 amRNSESOT Share Purchase
9th Apr 20212:53 pmRNSPublication of Annual Report & Notice of 2021 AGM
6th Apr 202110:39 amRNSESOT Share Purchase
26th Mar 20212:28 pmRNSESOT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.